Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV type 1 capsid protein (CA or p24) is a critical structural component of HIV-1. It forms the conical core protecting the viral RNA genome. CA plays essential roles throughout the viral life cycle, including genome protection, host interactions for trafficking and nuclear import, and viral maturation/uncoating. It's a validated antiviral drug target with small molecule inhibitors under development.
Inhibition of capsid assembly/disassembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus Type 1 Capsid Protein (CA).